420
Views
0
CrossRef citations to date
0
Altmetric
This article refers to:
A recombinant live attenuated tetravalent vaccine for the prevention of dengue

Guy B, Noriega F, Ochiai RL, et al. A recombinant live attenuated tetravalent vaccine for the prevention of dengue. Expert Rev Vaccines. 2017:1–13.

http://dx.doi.org/10.1080/14760584.2017.1335201

When the above article was first published online, there was an error in the annotation text under the reference number 33. This has been corrected in both print and online versions as described below.

The two publications above and references 35 and 37 below present key efficacy and safety results over the first 3 to 4 years of Phase III and Phase IIb efficacy trials with CYD-TDV.

Taylor & Francis apologizes for this error.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.